US EditionPublished • loading... • Updated
Analyzing Joe Rogan's effectiveness claims of psychedelic ibogaine
Fact-checkers found studies showing 23% to 55% of patients stayed opioid-free after a year, far below Rogan’s claim.
- President Donald Trump signed an executive order directing federal agencies to increase ibogaine research, while Rogan claimed at the White House that one dose frees more than 80% of people from opioid addiction.
- Ibogaine is a Schedule I drug derived from a West African shrub, traditionally recognized for acute benefits in reducing withdrawal symptoms and cravings rather than long-term opioid cessation.
- PolitiFact rated Rogan's claim 'Mostly False,' finding no research supporting more than 80% long-term cessation rates; published studies identify rates ranging only from 23% to 55% after a year.
- Researchers cite small sample sizes and observational study limitations, with one Harvard Review finding only about 30% of people abstained from opioids after 10 years of follow-up.
- Ohio State University professor Alan K. Davis, who co-authored a 2018 ibogaine survey, questioned where Rogan obtained his figures, while the drug remains illegal in many countries including the U.S.
Insights by Ground AI
Podcasts & Opinions
19 Articles
19 Articles
Analyzing Joe Rogan's effectiveness claims of psychedelic ibogaine
Podcaster Joe Rogan claimed the psychedelic drug ibogaine cured opioid addiction in 80% of the people who took one dose. PolitiFact looked at whether those effectiveness claims are accurate.
·Plattsburgh, United States
Read Full ArticleCoverage Details
Total News Sources19
Leaning Left0Leaning Right0Center19Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
